Your browser does not support iframes.
Regional Stocks
Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
REDHILL BIO SP ADS
(NQ:
RDHL
)
11.10
USD
-0.11 (-0.98%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 17, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Price and Volume
Detailed Quote
Intraday
1 Week
1 Month
3 Month
1 Year
Compare to:
None
S&P 500
Nasdaq
NYSE
AMEX
Russell 2000
Basic Materials
Conglomerates
Consumer Goods
Financial
Healthcare
Industrial Goods
Services
Technology
Utilities
Volume
0
Open
10.75
Bid (Size)
10.75 (600)
Ask (Size)
11.20 (200)
Prev. Close
11.21
Today's Range
10.75 - 11.21
52wk Range
8.457 - 14.50
Shares Outstanding
5,299,036
Dividend Yield
N/A
Top News
More News
RedHill Biopharma Reports Financial Results for the First Quarter of 2013
May 02, 2013
from
GlobeNewswire News Releases
Bioassociate Announces Valuation Report on RedHill Biopharma, Ltd.
April 03, 2013
from
PR Newswire
More News
Read More
IntelGenx Submits New Drug Application for Anti-Migraine VersaFilm(TM)
March 27, 2013
from
GlobeNewswire News Releases
RedHill Biopharma Submits New Drug Application to U.S. FDA for RHB-103 Anti-Migraine Oral Thin Film
March 27, 2013
from
GlobeNewswire News Releases
RedHill Biopharma Receives Positive Feedback From a Scientific Advice Meeting in Europe Regarding RHB-101 (Hypertension) Marketing Application Plan
March 19, 2013
from
GlobeNewswire News Releases
Roth Capital Starts Redhill Biopharma (RDHL) at Buy
March 14, 2013
from
StreetInsider.com News Articles
RedHill Biopharma to Present at the 25th Annual ROTH Conference
March 06, 2013
from
GlobeNewswire News Releases
RedHill Biopharma Provides Update on Development Progress and Planned NDA Submission for RHB-102 (Oncology Support Anti-Emetic)
February 25, 2013
from
GlobeNewswire News Releases
RedHill Biopharma Reports 2012 Fourth Quarter and Year-End Results
February 19, 2013
from
GlobeNewswire News Releases
RedHill Biopharma Announces Notice of Allowance From the United States Patent and Trademark Office for Its Cardio Drug RHB-101
February 19, 2013
from
GlobeNewswire News Releases
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here
Your browser does not support iframes.